arrow
M

Martin Aringer

heinrich heine university dusseldorf hospital
H指数:71
被引数:3.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Management of systemic lupus erythematosus-Including secondary antiphospholipid syndrome, fertility and pregnancy S3 guidelines of the German Society for Rheumatology and Clinical Immunology and the German Society for Neurology (DGN), German Society for Internal Medicine (DGIM), German Cardiac Society (DGK), Society for Thrombosis and Hemostasis Research (GTH), German Society for Hematology and Medical Oncology (DGHO), German Society for Pediatric and Adolescent Medicine (DGKJ), Society for Pediatric and Adolescent Rheumatology (GKJR), German Society for Nephrology (DGfN), German Society for Pneumology and Ventilation Medicine (DGP), German Rheumatism League National Association, Lupus Erythematosus Self-help Community, German Dermatological Society (DDG). Version: 1.2

系统性红斑狼疮的管理-包括继发性抗磷脂综合征、生育能力和妊娠 S3指南,德国风湿病和临床免疫学会及德国神经病学学会(DGN)、德国内科学会(DGIM)、德国心脏学会(DGK)、血栓与止血研究学会(GTH)、德国血液学和医学肿瘤学会(DGHO)、德国儿科和青少年医学学会(DGKJ)、儿科和青少年风湿病学会(GKJR)、德国肾病学会(DGfN)、德国肺病和呼吸医学学会(DGP)、德国风湿病联盟全国协会、红斑狼疮自助社区、德国皮肤病学会(DDG)。版本:1.2

2025-11-010
PRE
Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)

中重度系统性红斑狼疮患者的真实治疗模式和临床特征: 对SLE前瞻性观察队列研究 (SPOCS) 的分析

2025-01-230
OAAI
BELIMUMAB VERSUS PLACEBO IMPROVES DISEASE ACTIVITY AND REDUCES CUMULATIVE GLUCOCORTICOID DOSE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO WERE TREATMENT RESPONDERS: RESULTS OF A LARGE INTEGRATED ANALYSIS

贝利木单抗(Belimumab)优于安慰剂(Placebo),能够改善系统性红斑狼疮(Systemic Lupus Erythematosus)治疗应答患者的疾病活动度,并减少累积糖皮质激素剂量:一项大规模整合分析的结果

2024-06-010
PRE
Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature

系统性红斑狼疮在临床实践中的负担: 干扰素基因签名的SLE前瞻性观察队列研究 (SPOCS) 的基线数据

2023-12-209
OAAI
Evaluation of the EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population-Based Registry

基于人群的登记数据库中对EULAR/美国风湿病学会系统性红斑狼疮分类标准的评价

2023-01-113
OA
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
2022-12-090
OAAI
2021 DORIS definition of remission in SLE: final recommendations from an international task force
2021-11-24195
OAAI